Tags: generics | Mylan | Abbott | stock

Mylan to Buy Abbott's Non-US Specialty, Branded Generics Assets

Monday, 14 July 2014 06:55 AM

Generic drugmaker Mylan Inc. said it would buy Abbott Laboratories' specialty and branded generics business outside the United States in an all-stock transaction valued at about $5.3 billion.

Abbott will receive 105 million shares of the combined company.

© 2020 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
InvestingAnalysis
Generic drugmaker Mylan Inc. said it would buy Abbott Laboratories' specialty and branded generics business outside the United States in an all-stock transaction valued at about $5.3 billion.
generics, Mylan, Abbott, stock
38
2014-55-14
Monday, 14 July 2014 06:55 AM
Newsmax Media, Inc.
 
Newsmax TV Live

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
MONEYNEWS.COM
© Newsmax Media, Inc.
All Rights Reserved